-
Study aim
-
Investigating the effect and side effects of bupropion on fatigue, disability and quality of life of multiple sclerosis patients
-
Design
-
A controlled, parallel-group, double-blind, randomized, phase 2 clinical trial on 100 patients. Blocks of four will be used for randomization.
-
Settings and conduct
-
This study is a randomized clinical trial (blocks of four), double blind (participants and results analyzer), with parallel groups, without a control group and with the participation of 80 patients with multiple sclerosis referred to Imam Reza Hospital (Tabriz). will be done. In this study, the effects and complications of bupropion in patients will be investigated.
-
Participants/Inclusion and exclusion criteria
-
The most important criteria for entering the study include a definitive diagnosis of multiple sclerosis based on the MacDonald criteria, 2017 version, and an EDSS value of less than four, and the most important exclusion criteria include: the use of drugs that have a reducing or intensifying effect on fatigue, such as dalfampridine, modafinil, anti Depressants and other psychiatric drugs and the use of other auxiliary methods such as herbal medicines, antidepressants, yoga, unnecessary supplements, addiction or drug use.
-
Intervention groups
-
In this study, patients who will refer to the doctor due to multiple sclerosis will undergo intervention. Patients will be randomly divided into two groups. For one group, along with routine treatments, Bupropion drug will be prescribed and for another group, placebo drug will be prescribed along with routine drugs, and finally, the level of fatigue and quality of life will be compared in them.
-
Main outcome variables
-
Quality of life